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The anterior thalamus (AT) is critical for memory formation, processing navigational information, and seizure
initiation. However, the molecular mechanisms that regulate synaptic function of AT neurons remain largely
unexplored. We report that AMPA receptor auxiliary subunit GSG1L controls short-term plasticity in AT syn-
apses that receive inputs from the cortex, but not in those receiving inputs from other pathways. A canonical
auxiliary subunit stargazin co-exists in these neurons but is functionally absent from corticothalamic synap-
ses. In GSG1L knockout mice, AT neurons exhibit hyperexcitability and the animals have increased suscep-
tibility to seizures, consistent with a negative regulatory role of GSG1L. We hypothesize that negative regu-
lation of synaptic function by GSG1L plays a critical role in maintaining optimal excitation in the AT.
INTRODUCTION
Regulation of excitatory synaptic transmission is essential for
synaptic plasticity, learning, andmemory. AMPA-type ionotropic
glutamate receptors (AMPARs), which are ligand-gated ion
channels activated by the neurotransmitter glutamate, play a
key role in this process by mediating most fast excitatory neuro-
transmission in the brain (Bowie, 2008; Traynelis et al., 2010; Hu-
ganir and Nicoll, 2013). GluA1–GluA4 are the pore-forming sub-
units of AMPARs that assemble into functional ligand-gated ion
channels consisting of homo- and heterotetramers (Greger et al.,
2017). The canonical structural units of native AMPARs are com-
plexes composed of the core tetramers of GluA subunits and
their auxiliary subunits (Nakagawa et al., 2005; Schwenk et al.,
2012; Zhao et al., 2019).
AMPAR auxiliary subunits are membrane proteins that regu-
late ion channel gating and trafficking of AMPARs (Jackson
and Nicoll, 2011). The most extensively studied among these
are the stargazin/TARPs (transmembrane AMPAR regulatory
proteins) (Tomita et al., 2003). Other auxiliary subunits include
cornichon homologs 2 and 3 (CNIH2/3) (Schwenk et al., 2009),
CKAMP44 (also known as Shisa9) (von Engelhardt et al., 2010),
Shisa6 (Klaassen et al., 2016), SOL-1 (Zheng et al., 2004), and
GSG1L (Schwenk et al., 2012; Shanks et al., 2012). Each class
of auxiliary subunits is structurally unrelated to the others except
for GSG1L and TARPs, which are both claudin homologs. Mod-
ulation of AMPARs by auxiliary subunits is predicted to substan-
tially affect brain function (Jackson and Nicoll, 2011). Mutations
in one or more AMPAR auxiliary subunits lead to neurological
and cognitive deficits in both mice and humans (Everett et al.,
2007; Hamdan et al., 2011; Floor et al., 2012).
Most AMPAR auxiliary subunits positively modulate AMPAR
function by promoting synaptic trafficking and/or modifying
gating toward increasing net charge transfer (Jackson and Nic-
oll, 2011). A subset of auxiliary subunits has mixed effects on
gating. For example, CKAMP44 slows AMPAR deactivation,
increasing net charge transfer during synaptic transmission,
but also delays recovery from desensitization so that the channel
is not immediately re-usable (von Engelhardt et al., 2010). Simi-
larly, TARP g-8 slows AMPAR desensitization and delays recov-
ery from AMPAR desensitization of GluA2 and GluA3 specifically
(Cais et al., 2014). Among all auxiliary subunits, GSG1L stands
out for having a strong negative modulatory function (McGee
et al., 2015; Gu et al., 2016; Mao et al., 2017) (summarized in Fig-
ure 1A). Although GSG1L also slows desensitization, it stabilizes
the desensitized state (Twomey et al., 2017b) and dramatically
delays recovery from desensitization over a magnitude slower
than other auxiliary subunits (Schwenk et al., 2012; Shanks
et al., 2012). In addition, GSG1L reduces single-channel conduc-
tance and calcium permeability of calcium-permeable AMPARs
(McGee et al., 2015). Consistently, overexpression of GSG1L de-
creases the amplitude of evoked excitatory postsynaptic
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currents (EPSCs) (McGee et al., 2015; Gu et al., 2016; Mao et al.,
2017).
Despite its pronounced negative phenotype on AMPAR mod-
ulation, GSG1L expression in the brain is low (Schwenk et al.,
2014), and it is unclear to what extent it is used in vivo. In partic-
ular, previous studies using GSG1L knockout (KO) rats reported
a modest phenotype in the hippocampus and failed to identify
synapses that express the signatures of GSG1L-dependent
AMPAR gating modulation, compounded by co-expression of
another auxiliary subunit, CNIH2 (Gu et al., 2016).
Here, we demonstrate that GSG1L is enriched in anterodorsal
nucleus (AD) and anteroventral nucleus (AV) in the anterior thal-
amus (AT). The AT is important for memory formation (Aggleton
and Brown, 1999; Wolff et al., 2006), encoding head direction in-
formation during spatial navigation (Clark and Taube, 2012), as
well as seizure initiation and propagation (Mirski and Ferrendelli,
1984; Hamani et al., 2004; Takebayashi et al., 2007; Bittencourt
et al., 2010). However, the molecular mechanisms that regulate
synaptic function of the AT remain largely unexplored. We find
that GSG1L has a postsynaptic role in regulating short-term
plasticity in synapses that receive inputs from the cortex, but
not from the subiculum or the mammillary bodies (MBs). Further-
more, loss of GSG1L results in increased susceptibility to kai-
nate-induced seizures.
RESULTS
GSG1L Is Sufficient to Express Short-Term Plasticity
In Vitro
The most significant action of GSG1L is the slowing of AMPAR
recovery from desensitization (Figure 1A) (Schwenk et al.,
2012; Shanks et al., 2012). Therefore, in synapses in which
AMPARs desensitize, GSG1L should prevent immediate re-use
of AMPARs during repetitive activation and as a result promote
short-term depression (STD) or attenuate short-term facilitation.
Conversely, elimination of GSG1L should relieve STD or, in an
extreme case, convert to short-term facilitation. Consistent
with this hypothesis, GSG1Lwas sufficient to induce STD in a re-
constituted system (Figures 1B–1E). Indeed, we found that
outside-out patches pulled from HEK293 cells that co-express
GSG1L and GluA2 (flip splice variant with unedited Q pore)
show significantly depressing currents in response to 1 mM
glutamate pulses of 1 ms at 20 Hz, whereas in the absence of
GSG1L, the amplitudes remained constant (Figures 1B–1E).
High and Persistent Expression of GSG1L in the AT
We determined the spatiotemporal expression of GSG1L using a
transgenic rat that expresses a lacZ reporter under the control of
the GSG1L promoter (Figures S1A and S1B). High expression of
GSG1L was found in the AT throughout development (Figures 1F
and S1C). GSG1L is restricted to AD and AV but absent from an-
teromedial nucleus (AM) or lateral dorsal nucleus (LD), in agree-
ment with in situ hybridization data from the Allen Brain Atlas
(Figures 1G, S1D, and S1E) (Lein et al., 2007). AD and AV share
progenitor origin (Shi et al., 2017), expression profile of neuro-
transmitter receptors (Phillips et al., 2019), and afferent and
efferent projections (Jankowski et al., 2013). Therefore, we
treated the two as a single nucleus, AD/AV, in our investigation.
AD/AV receives dense projections from the retrosplenial cortex,
the subiculum, and the MB via the mammillothalamic tract (MTT)
(Wright et al., 2010) (Figures 1H and 1I). By directly stimulating
each afferent, we could selectively record evoked postsynaptic
responses from individual inputs (see STAR Methods and Fig-
ure 1I) (Petrof and Sherman, 2009; Oh et al., 2014). Analogous
to the sensory thalamic relay circuits (Sherman and Guillery,
2004), the inputs to AD/AV neurons are classified into driver
and modulator inputs. Specifically, MB inputs drive the firing of
AD/AV neurons, whereas cortical and subiculum inputs modu-
late the action of the MB inputs (Petrof and Sherman, 2009).
Input-Specific Modulation of Short-Term Plasticity by
GSG1L
Inputs to AD/AV neurons undergo varying degrees of short-term
plasticity upon repetitive stimulation (Petrof and Sherman, 2009).
Figure 1. GSG1L Input Specifically Regulates Short-Term Plasticity at AD/AV
(A) Ribbon diagram of GluA2 (red) with or without GSG1L (blue) (PDB: 5WEK) (Twomey et al., 2017a). Schematic summarizing the effects of GSG1L, emphasized
with black arrows (right). AMPAR+GSG1L (blue lines) exhibits decreased amplitude and slower recovery from desensitization compared with AMPAR alone (red
lines).
(B–E) Recordings from outside-out patches. Representative averaged traces for (B) GluA2iQ (i.e., flip/Q pore) alone and (C) GluA2iQ+GSG1L. OTR, open tip
response. (D) Magnified view of the OTR. (E) Ratio of each pulse over the first pulse (Ix/I1, where x = 2, 3, and 4). A2iQ (n = 5), A2iQ+GSG1L (n = 4) (p < 0.001 for
pulses 2–4, two-way ANOVA).
(F) GSG1L KO rat brain coronal sections at P21 (scale bar, 1,000 mm). The lacZ expression is represented by dark blue stain (arrowheads show AD/AV).
(G) In situ hybridization data from the Allen Brain Atlas. The lower signal intensity in AV reflects lower cell density in AV compared with AD (Morel et al., 1997); see
also Figure S1E.
(H) Inputs received by AD/AV.
(I) Input-dependent stimulation paradigm of AD/AV (scale bar, 420 mm). Brain images were derived from Allen brain connectivity (scale bar, 1,000 mm) (Oh et al.,
2014).
(J, M, and P) Schematic of mammilothalamic, M-T pathway (J), subiculum-thalamic, S-T pathway (M), and corticothalamic, C-T pathway (P).
(K) Pulse ratios of electrically evoked EPSCs from AD/AV neurons at a holding potential of70 mV of GSG1L KO (P21–P33, n = 15 cells, N = 6 mice), Het (n = 13,
N = 5), and WT (n = 20, N = 8). S1–S5 are amplitudes of each stimulus in a train of five stimuli (p = 0.9956, two-way ANOVA). S(n)/S1, where n = 2, ., 5, is the
paired-pulse ratio of the 2nd–5th pulse divided by the 1st pulse.
(L, O, and R) Superimposed sample traces of whole-cell recordings of currents in AD/AV in response to stimulating M-T (L), S-T (O), or C-T (R) pathway.
(N) No changes in pulse ratios of GSG1L KO (P21–P33, n = 18, N = 6), Het (n = 20, N = 6), and WT (n = 18, N = 7) (p = 0.7288, two-way ANOVA) in response to
subiculum stimulation at 20 Hz.
(Q) Pulse ratios are significantly different for GSG1L KO (P21–P33, n = 13, N = 6), Het (n = 14, N = 6), andWT (n = 19, N = 7) at 20 Hz (p < 0.0001, two-way ANOVA) in
response to cortical stimulation. Post hoc Sidak comparisons: **p < 0.01, ***p < 0.001, ****p < 0.0001.
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Given the high expression of GSG1L in AD/AV neurons, we
wondered whether GSG1L is responsible for short-term plas-
ticity. To address this, the extent of short-term plasticity in AD/
AV neurons was compared between GSG1L KO and wild-type
(WT) mice (Figures S1F–S1I). Sagittal sections were used to re-
cord from mammillothalamic (M-T) and subiculum-thalamic
(S-T) synapses, whereas coronal sections were used to obtain
corticothalamic (C-T) synapses (Figure 1I). We electrically stimu-
lated the MB inputs (i.e., MTT) at 20 and 50 Hz while whole-cell
recording from AD/AV neurons (Figures 1J–1L and S2A–S2C).
The degree of synaptic depression in the M-T synapses was
quantified by taking amplitude ratios of the first stimulus (S1)
and following four stimuli (S2–S5) responses. There was no
statistical difference between GSG1L KO and WT control litter-
mates (Figures 1J–1L and S2A–S2C). Similar results were ob-
tained when inputs from the subiculum, the S-T synapses,
were examined at 20 and 50 Hz (Figures 1M–1O and S2D–
S2F). In contrast, stimulation of the C-T pathway of GSG1L
KO, at both 20 and 50 Hz, resulted in enhanced synaptic facilita-
tion, relative toWT control and heterozygous littermates (Figures
1P–1R and S2G–S2I). Similar findings were obtained when only
AD synapses were examined, consistent with the close cellular
pedigree of neurons in AD and AV (Shi et al., 2017) (Figures
S2J–S2M).
Changes in the presynaptic glutamate release would affect
both AMPARs and NMDA receptors (NMDARs). If short-term
plasticity were mediated by a presynaptic mechanism, one
would expect to find the effect of the genotype in both AMPAR-
and NMDAR-mediated EPSCs. Therefore, to exclude the possi-
bility of a presynaptic effect, we examined short-term plasticity
of NMDAR-mediated EPSCs in the C-T synapses in response
to 20 and 50Hz stimulations (Figures S3A–S3E).We found no dif-
ferences between GSG1L KO and control littermates, indicating
that the effect is postsynaptic and AMPAR dependent. Input-
specific stimulation of the C-T pathway unveiled the postsyn-
aptic role of GSG1L, where its deletion is associated with
enhanced synaptic short-term facilitation. Collectively, these re-
sults suggest that GSG1L input specifically regulates synaptic
plasticity at AD/AV.
AMPAR Desensitization Occurs at C-T Synapses of AD/
AV Neurons
If GSG1L regulates C-T synapses by altering the rate of recovery
fromdesensitization of postsynaptic AMPARs, desensitization of
AMPAR must be occurring during synaptic transmission. A sim-
ple way to test this is to examine sensitivity of evoked EPSCs to
cyclothiazide (CTZ), a blocker of AMPAR desensitization. In
GSG1LWTmice, whole-cell recordings from AD/AV neurons de-
tected a significant increase in the degree of synaptic facilitation
upon addition of 100 mMCTZwhile stimulating the cortical inputs
at 20 and 50 Hz in the presence picrotoxin, a blocker of g-amino-
butyric acid (GABA) A receptors (Figures S3F–S3J). Importantly,
CTZ sensitivity in C-T synapses requires GSG1L, because it is
absent from GSG1L KO (Figures S3F–S3J). This substantiates
our hypothesis that GSG1L affects short-term plasticity in these
synapses through a postsynaptic mechanism of slowing AMPAR
recovery from desensitization.
GSG1L Modulates Basal Synaptic Transmission at C-T
Synapses
Another predicted signature of synapses regulated by GSG1L is
the reduction of amplitude of AMPAR-mediated responses (Fig-
ure 1A) (McGee et al., 2015). Thus, we next investigated whether
GSG1L also regulates basal AMPAR-mediated synaptic trans-
mission by recording AMPAR-mediated miniature EPSCs
(mEPSCs) in AD/AV neurons from GSG1L KO and WT mice (Fig-
ures 2A–2D). We found no significant differences in the average
amplitude or the frequency of AMPAR-mediatedmEPSCs. How-
ever, upon careful inspection, we found that there was a subset
of GSG1L KO neurons with enhanced amplitude of mEPSCs
(Figure 2C). This is in agreement with GSG1L functionally regu-
lating a subset of synapses, specifically those formed by C-T in-
puts (Figure 1).
To directly test whether GSG1L regulates basal synaptic
transmission at C-T synapses, we recorded asynchronous
quantal EPSCs (qEPSCs) evoked in the presence of strontium
(4 mM SrCl2) (Figures 2E–2L). Synaptic responses produced by
isolated asynchronous quantal events represent postsynaptic
AMPAR activity in the evoked pathway (Goda and Stevens,
Figure 2. GSG1L Is a Negative AMPAR Regulator at C-T Synapses in AD/AV
(A) Mean amplitude and frequency of AMPAR-mediated mEPSCs in AD/AV of GSG1L KO and GSG1LWT (p = 0.3082, p = 0.4054, respectively, Mann-Whitney U
test). GSG1L KO (P15–P30, n = 47, N = 4); GSG1L WT (n = 33, N = 3).
(B) Cumulative plot of the amplitude distribution (p = 0.0041, Kolmogorov-Smirnov [K-S] test).
(C) Histogram of amplitudes of individual cells.
(D) Representative traces of AMPAR-mediated mEPSCs in each genotype.
(E, M, and P) Asynchronous qEPSCs recorded at C-T (E), M-T (M), or S-T (P) synapses at AD/AV in GSG1L WT and KO.
(F and G) Amplitude (P15–P30, p = 0.0378, Mann-Whitney U test) (F) and frequency (G) of qEPSCs (p = 0.0060, Mann-Whitney U test) comparing GSG1L KO (n =
11, N = 4) and WT (n = 11, N = 5).
(H) Representative traces of qEPSCs.
(I and J) Pooled data for rise time (p = 0.0900, Mann-Whitney U test) (I) and decay kinetics (p = 0.0413, Mann-Whitney U test) (J). Each data point is an average
obtained from one neuron.
(K) Representative traces of averaged qEPSCs from one neuron in GSG1L WT (red) and KO (blue). Raw traces are shown in gray.
(L) Averaged qEPSCs in (K) are normalized and overlaid for comparison.
(N) Amplitude (p = 0.4455, Mann-Whitney U test) and frequency (p = 0.0535, Mann-Whitney U test) of M-T qEPSCs comparing GSG1L KO (n = 11, N = 5) and WT
(n = 8, N = 6).
(O and R) Representative traces of qEPSCs from the M-T pathway (O) and S-T pathway (R) in GSG1L WT and KO.
(Q) Amplitude (p = 0.2184, Mann-Whitney U test) and frequency (p = 0.3269, Mann-Whitney U test) of S-T qEPSCs of GSG1L KO (n = 18, N = 5) and WT
(n = 12, N = 6).




Figure 3. GSG1L Is a Dominant Auxiliary Subunit at C-T Synapses at AD/AV
(A)Mean amplitude of AMPAR-mediatedmEPSCs in AD/AV of g-2 KO and g-2WT (p = 0.0006,Mann-Whitney U test). g-2 KO (P15–P22, n = 24, N = 3); g-2WT (n =
24, N = 3).
(legend continued on next page)




1994). We found that the amplitude of asynchronous qEPSCs is
enhanced in GSG1L KO animals relative to WT control (Figures
2E–2H). The frequency of qEPSCs was also higher in GSG1L
KOC-T synapses,most likely because of an increase in apparent
detection sensitivity caused by an increase in the amplitudes. In
addition, consistent with GSG1L’s role in modulating AMPAR
gating kinetics (Schwenk et al., 2012; Shanks et al., 2012), the ki-
netics of C-T qEPSCs are accelerated in GSG1L KO. Although
the difference in the rise time of qEPSCs was not significant
(p = 0.0900), the decay time was significantly reduced in
GSG1L KO (Figures 2I–2L).
Consistent with GSG1L having an input-specific function at
AD/AV, there were no significant differences in the amplitude
or frequency of asynchronous qEPSCs between GSG1L KO
and WT in M-T synapses (Figures 2M–2O) or S-T synapses (Fig-
ures 2P–2R). The kinetics of qEPSCs in these two pathwayswere
unaltered between GSG1L KO and WT (Figures S3K–S3P).
Functional Co-expression of GSG1L and Stargazin in
AD/AV Neurons
Using the results of the Allen Brain Atlas as a reference, we in-
ferred that stargazin is the dominant type I TARP expressed in
AD/AV neurons (Figures S4A–S4E). A previous study has shown
that stargazin outcompetesGSG1L in AMPARgatingmodulation
in Xenopus oocytes (Schwenk et al., 2012). To test the hypothe-
sis that stargazin and GSG1L both modulate AMPARs at synap-
ses in AD/AV neurons, we investigated the effect of deleting
stargazin using a g-2 KO mouse generated in our lab (Figures
S4F–S4J).
In stargazer mice (i.e., spontaneously occurred g-2 KO mice),
there is complete loss of functional synaptic AMPARs in cere-
bellar granule cells (Hashimoto et al., 1999; Chen et al., 2000).
In contrast, we found that in AD/AV neurons, there is residual
AMPAR activity in g-2 KO mice. Consistent with stargazin being
a positive AMPAR regulator, both the amplitude and the fre-
quency of AMPAR-mediated mEPSCs are lower in g-2 KO rela-
tive to WT control (Figures 3A–3D). The residual mEPSCs indi-
cate the existence of a subset of synapses with functional
AMPARs. We predicted that these are C-T synapses do not
have stargazin regulation but instead are controlled by GSG1L.
We found no significant differences in the amplitude or the fre-
quency of asynchronous qEPSCs between g-2 KO and WT in
C-T synapses (Figures 3E–3G). These results suggest that g-2
plays a minimal role regulating C-T synapses in AD/AV neurons
in the presence of GSG1L.
We predicted that stargazin is a dominant auxiliary subunit in
M-T and S-T synapses, whereas GSG1L exclusively regulates
C-T synapses. Consistent with this hypothesis, we found that
removal of stargazin from AD/AV neurons unmasks the basal
postsynaptic modulatory effect of GSG1L in GSG1L/g-2 dou-
ble-knockout (dKO) mice (Figures 3H–3K). Namely, both the
amplitude and the frequency of mEPSCs are significantly
increased in GSG1L/g-2 dKO mice relative to GSG1L WT/g-2
KO and GSG1L Het/g-2 KO. Furthermore, consistent with the
role of GSG1L in slowing AMPAR kinetics, both the rise time
and the decay time of mEPSCs are significantly reduced in
GSG1L/g-2 dKO relative to GSG1L WT/g-2 KO neurons (Fig-
ures 3L–3N). Altogether, these findings indicate that under
basal conditions, stargazin outcompetes GSG1L in modulating
AMPARs in M-T and S-T synapses. The action of GSG1L on
basal synaptic transmission is fully unmasked in the GSG1L/
g-2 dKO mouse.
Increased Hyperexcitability and Enhanced Seizure
Susceptibility in GSG1L KO
Having established the synaptic function of GSG1L, we next
investigated whether the loss of GSG1L would result in circuit-
level changes in excitability. To test this, we recorded sponta-
neous action potential firing of AD/AV neurons in current-clamp
modewith no current injection. We found that 60%of GSG1L KO
AD/AV neurons spiked during a 3-min recording period, whereas
only 15% spiked in WT neurons (Figures 4A–4C). There was no
change in intrinsic excitability of neurons in GSG1L KO, because
no differences were observed in the resting membrane potential,
rheobase, and neuronal firing rate between GSG1L KO and WT
control (Figures S5A–S5D). However, the input resistance is
significantly reduced in GSG1L KO mice (Figure S5E), which is
consistent with increased synaptic activity, although it may not
be the sole cause of the effect. In addition, we found that
spontaneous excitatory synaptic transmission is significantly
enhanced in GSG1L KO mice (Figures 4D–4F), as well as in
GSG1L/g-2 dKO mice (Figures S5F–S5I). Both the amplitude
and the frequency of AMPAR-mediated spontaneous EPSCs
(sEPSCs) are increased in GSG1L KO neurons. Altogether, neu-
rons in AD/AV neurons of GSG1L KO mice are hyperactive
overall.
(B) Frequency of mEPSCs (p < 0.0001, Mann-Whitney U test).
(C) Cumulative plot of the amplitude distribution between g-2 KO and WT animals (p = 0.024, K-S test).
(D) Representative AMPAR-mediated mEPSC traces of AD/AV neurons.
(E and F) Asynchronous qEPSCs recorded at C-T synapses at AD/AV in g-2 WT (P15–P22, n = 17, N = 6) and KO (n = 18, N = 6). Mean amplitude (p = 0.4123,
Mann-Whitney U test) (E) and frequency (p = 0.4578, Mann-Whitney U test) (F) of qEPSCs.
(G) Representative traces of qEPSCs at C-T synapses.
(H) Mean amplitude of AMPAR-mediated mEPSCs in AD/AV of GSG1L KO/g-2 KOmice relative to the GSG1LWT/g-2 KO and GSG1L Het/g-2 KO (P15–P22, p <
0.0001, two-way ANOVA). GSG1L WT/g-2 KO (n = 45, N = 6); GSG1L HET/g-2 KO (n = 37, N = 5); GSG1L KO/g-2 KO (n = 36, N = 5).
(I) Frequency of mEPSCs (p = 0.0003, two-way ANOVA).
(J) Cumulative plot showing amplitude distribution (p = 0.0166, K-S test).
(K) Representative AMPAR-mediated mEPSC traces from corresponding genotypes.
(L andM) Rise time (p = 0.0277, Mann-Whitney U test) (L) and decay time (p = 0.0058, Mann-Whitney U test) (M) of mEPSCs in GSG1L KO/g-2 KO (blue) relative to
GSG1L WT/g-2 KO (red).
(N) Representative traces of averagedmEPSCs, with the averages shown in bold. The averages of individual mEPSCs are normalized and overlaid for comparison
with GSG1L KO/g-2 KO in blue and GSG1L WT/g-2 KO in red. Post hoc Sidak comparisons: *p < 0.05, ***p < 0.001, ****p < 0.0001.




Figure 4. Loss of GSG1L Results in Enhanced Excitability and Seizure Susceptibility
(A) Bar graph summarizing spontaneously firing AD/AV neurons in GSG1L KO (20/33 cells, N = 5) and WT control (5/33 cells, N = 5).
(B) Representative traces of two spiking GSG1L KO AD/AV neurons.
(C) Bar graph summarizing firing frequency distribution. Blue and red data points represent left and right traces in (B), respectively.
(D and E) Mean amplitude (p = 0.0037, Mann-Whitney U test) and frequency (p = 0.0084, Mann-Whitney U test) of AMPAR-mediated sEPSCs in AD/AV neurons of
GSG1L KO (P15–P30, n = 17, N = 4) and WT (n = 18, N = 4).
(F) Representative sEPSC traces of GSG1L KO and WT.
(G–J) Time course of seizure severity following i.p. injection of 15 mg/kg (n = 13 each, 9–10 months) (G) or 25 mg/kg (n = 8 each) (I) of kainate. A higher score
corresponds to a severer seizure status, with 7 denoting death. (H and J) Mortality rate during the 2-h recording period at 15 mg/kg (H) and 25 mg/kg (J) injection.
Two-way ANOVA, p < 0.0001 for both doses. Post hoc Sidak comparisons: *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
(legend continued on next page)




Next, we aimed to evaluate the effect of the loss of GSG1L at
the organism level. Initial basic behavioral phenotyping of
GSG1L KOmice revealed no differences in grip strength, rotarod
performance, elevated zero maze, and gait parameters (Figures
S5J–S5M). However, we found that GSG1L KO mice show def-
icits in a novel object recognition (NOR) task (Figure S5N), similar
to the findings of previous reports using GSG1L KO rats (Gu
et al., 2016). These results are consistent with the known role
of AT in learning and memory (Parker and Gaffan, 1997), but a
more drastic behavioral phenotype was revealed when the ani-
mals were challenged with seizure, a condition in which AT plays
a critical role (Mirski and Ferrendelli, 1984; Bittencourt et al.,
2010).
We found that GSG1L KO mice exhibit enhanced susceptibil-
ity to kainate-induced seizures (Figures 4G–4J). The seizure
severity was determined on a scale of 0–7, a rating system
with increasing severity in an ascending scale and with a score
7 denoting death (Morrison et al., 1996). At a lower-dose injection
(15mg/kg intraperitoneal [i.p.]) of kainate, GSG1L KOmice had a
significantly higher seizure severity score than WT controls.
Furthermore, 23% (3 of 13 mice) of GSG1L KO mice, and no
GSG1L WT mice, died within 2 h after kainate administration.
At a higher-dose injection (25 mg/kg i.p.) of kainate, 75% of
GSG1L KO mice died within 2 h postinjection and only 25%
of WT mice. These results highlight the in vivo importance of
GSG1L in protecting against kainate-induced neurotoxicity and
pathological hyperexcitability. Consistent with GSG1L being a
negative regulator of AMPAR function, GSG1L KO mice have
enhanced excitatory neurotransmission and susceptibility to
seizures, along with increased spontaneous firing of AD/AV
neurons.
DISCUSSION
AD/AV, where GSG1L is abundantly expressed, is at the core of
the extended hippocampal-diencephalic network with crucial
roles in memory (Aggleton and Brown, 1999); thus, AD/AV dam-
age is associated with anterograde amnesia (Ghika-Schmid and
Bogousslavsky, 2000; Gold and Squire, 2006). AD/AV contains
neurons that sense head direction during spatial navigation
(Clark and Taube, 2012) and have been implicated in seizure initi-
ation and/or propagation (Mirski and Ferrendelli, 1984; Kerrigan
et al., 2004). In contrast to the extensively studied lateral genic-
ulate nucleus (LGN), molecular and functional characterization of
the synapses of AD/AV is largely lacking.
We found that GSG1L and stargazin are functionally co-ex-
pressed in AD/AV. Among the synapses in AD/AV neurons
formed by three distinct input projections, C-T synapses are
controlled by GSG1L, but not by stargazin (Figures 1, 2, and 3).
In C-T synapses, GSG1L reduces the amplitude and slows the
kinetics of AMPAR-mediated qEPSCs and suppresses short-
term facilitation by slowing recovery from desensitization.
GSG1L promotes surface expression of AMPARs in HEK cells
and hippocampal neurons (Shanks et al., 2012; Gu et al.,
2016), and such a mechanism may partially contribute to the
properties of C-T synapses. However, we suggest that the effect
of GSG1L on gating modulation plays a dominant role in regu-
lating short-term plasticity given the CTZ sensitivity of these syn-
apses in WT, but not in GSG1L KO (Figures S3F–S3J).
In contrast to GSG1L, stargazin plays a major role in M-T or
S-T synapses (Figure 4K). Themechanism that restricts the func-
tions of GSG1L and stargazin to specific afferent synapses
remains to be determined. We speculate that presynaptic termi-
nals may provide some trans-synaptic molecular cues, consid-
ering that GSG1L lacks a PDZ (PSD-95, dlg, ZO-1) domain bind-
ing motif in the cytoplasmic C terminus as it would normally
facilitate synaptic anchoring.
In Xenopus oocytes, stargazin outcompetes GSG1L in
AMPAR modulation (Schwenk et al., 2012), which agrees with
GSG1L and stargazin sharing identical binding sites on AMPARs
(Twomey et al., 2016, 2017b). In AD/AV, we also found that under
basal conditions, stargazin outcompetes GSG1L, functionally, in
most synapses (Figures 3H–3N). The effect of GSG1L is un-
masked in GSG1L/g-2 dKO mice. These observations also indi-
cate that in AD/AV, the C-T synapses are the smaller population
compared with the combined sets of M-T and S-T synapses.
Similar to GSG1L, CKAMP44 slows recovery from desensiti-
zation, modulates short-term plasticity, and is expressed in
AD/AV (Figure S4E) (von Engelhardt et al., 2010; Chen et al.,
2018). We found that M-T synapses in AD/AV undergo pro-
nounced STD (Figures 1J–1L and S2A–S2C), which is highly sen-
sitive to CTZ (data not shown). Given that GSG1L does not
modulate AMPARs at M-T synapses, we speculate that
CKAMP44 could be postsynaptically functional in these synap-
ses, which has yet to be investigated. Again, input-specific func-
tional expression of an AMPAR auxiliary subunit in the thalamus
may extend to the case of CKAMP44.
Consistent with GSG1L being a negative regulator of AMPAR
function, deletion of GSG1L results in hyperexcitability in the AT
(Figure 4), with its impact observed in the downstream cortical
neurons (data not shown). Moreover, GSG1L KO mice have
enhanced susceptibility to kainate-induced seizures. We sug-
gest that disturbed excitation/inhibition (E/I) balance in GSG1L
KO is associated with seizure states (Bateup et al., 2013; Paz
and Huguenard, 2015; Staley, 2015). Circumstantial evidence
suggests GSG1L may serve a neuroprotective role against hy-
perexcitability and ischemia (Keum and Marchuk, 2009; Du
et al., 2015). GSG1Lwas identified as one of the candidate genes
at the locus that determines the extent of infarct volume inmouse
models of focal cerebral ischemia (Keum and Marchuk, 2009).
Furthermore, a suggestive single-nucleotide polymorphism in
GSG1L was found to be associated with infarct volume upon
ischemic stroke in mice and human patients (Du et al., 2015).
However, these are correlative studies, and further investigation
(K and L) Summary schema. (K) GSG1L is a dominant auxiliary subunit in C-T synapses (red) of AD/AV neurons (blue). In these synapses, GSG1L suppresses
short-term facilitation by slowing recovery from AMPAR desensitization. g-2 (Stg) is a dominant auxiliary subunit in S-T synapses (green) and M-T synapses
(yellow) in AD/AV. (L) Consistent with GSG1L being a negative regulator of AMPARs, GSG1L KO mice have increased AMPAR-mediated quantal events in C-T
synapses. GSG1L KO mice have enhanced excitability in the AT. The enhanced hyperexcitability is accompanied by increased susceptibility to kainate-induced
seizures in GSG1L KO mice.




is needed to the test the direct link between GSG1L and
ischemia.
Previous investigations on the synaptic phenotypes of GSG1L
KO rats in CA1 and DG (dentate gyrus) neurons (Gu et al., 2016;
Mao et al., 2017) were both conducted at time points when the
expression of the lacZ reporter for GSG1L promoter activity is
low (Figures S1C and S1D). Specifically, GSG1L KO rat acute sli-
ces at postnatal day (P) 13–P19 were used. Although GSG1L
protein is detectable in a subset of dendritic spines in older neu-
rons (Schwenk et al., 2012; Shanks et al., 2012; Willems et al.,
2020), the overall expression of GSG1L may be low in the hippo-
campus compared with the AT at young age (i.e., P13–P19). In
agreement with such a hypothesis, a previous study on GSG1L
KO rat reported a substantial contribution of another auxiliary
subunit, CNIH2, superimposed on the functional effect of
GSG1L (Gu et al., 2016). However, because the lacZ reporter
is an indirect indicator of GSG1L protein expression, future
studies using more direct methods are necessary to determine
whether its expression is low in young hippocampus.
AMPAR desensitization is critical for normal brain function
(Christie et al., 2010). CKAMP44 regulates AMPAR desensitiza-
tion and contributes to the underlying mechanism of STD in ret-
inogeniculate synapses (Chen et al., 2018, 2000; Kielland and
Heggelund, 2002; Budisantoso et al., 2012). The glomerular
structure of the retinogeniculate synapse has large terminals
and closely spaced release sites (Rafols and Valverde, 1973).
The unique overall geometry prevents fast removal of glutamate
and allows spillover, resulting in AMPAR desensitization (Budi-
santoso et al., 2012). However, the corticogeniculate synapses
have single distant synaptic contacts (Erisxir et al., 1997; Narush-
ima et al., 2016) with low release probability (Granseth et al.,
2002). In these synapses, AMPAR desensitization is predicted
to not contribute to short-term plasticity, such as observed in
the ventrobasal nucleus (Sun and Beierlein, 2011). CKAMP44
plays no role in short-term plasticity at corticogeniculate synap-
ses in the LGN (Chen et al., 2018). In contrast, we found that
AMPAR desensitization substantially contributes to short-term
plasticity at C-T synapses in AD/AV. GSG1L is highly expressed
in AD/AV (Figures 1 and S1), but not in the LGN or ventrobasal
nuclei of the thalamus (Lein et al., 2007). Hence, it is uniquely
positioned to regulate short-term plasticity in C-T synapses in
AD/AV, despite its predicted ultrastructure and low release
probability.
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omics identify cornichon proteins as auxiliary subunits of AMPA receptors.
Science 323, 1313–1319.
Schwenk, J., Harmel, N., Brechet, A., Zolles, G., Berkefeld, H., M€uller, C.S.,
Bildl, W., Baehrens, D., H€uber, B., Kulik, A., et al. (2012). High-resolution pro-
teomics unravel architecture and molecular diversity of native AMPA receptor
complexes. Neuron 74, 621–633.
Schwenk, J., Baehrens, D., Haupt, A., Bildl, W., Boudkkazi, S., Roeper, J., Fa-
kler, B., and Schulte, U. (2014). Regional diversity and developmental dy-
namics of the AMPA-receptor proteome in the mammalian brain. Neuron 84,
41–54.
Shanks, N.F., Savas, J.N., Maruo, T., Cais, O., Hirao, A., Oe, S., Ghosh, A.,
Noda, Y., Greger, I.H., Yates, J.R., 3rd, and Nakagawa, T. (2012). Differences
in AMPA and kainate receptor interactomes facilitate identification of AMPA
receptor auxiliary subunit GSG1L. Cell Rep. 1, 590–598.
Sherman, S.M., and Guillery, R.W. (2004). Thalamus. In The Synaptic Organi-
zation of the Brain, G.M. Shepherd, ed. (Oxford University Press), pp. 311–359.
Shi, W., Xianyu, A., Han, Z., Tang, X., Li, Z., Zhong, H., Mao, T., Huang, K., and
Shi, S.H. (2017). Ontogenetic establishment of order-specific nuclear organi-
zation in the mammalian thalamus. Nat. Neurosci. 20, 516–528.
Staley, K. (2015). Molecular mechanisms of epilepsy. Nat. Neurosci. 18,
367–372.
Sun, Y.G., and Beierlein, M. (2011). Receptor saturation controls short-term
synaptic plasticity at corticothalamic synapses. J. Neurophysiol. 105, 2319–
2329.
Takebayashi, S., Hashizume, K., Tanaka, T., and Hodozuka, A. (2007). The ef-
fect of electrical stimulation and lesioning of the anterior thalamic nucleus on
kainic acid-induced focal cortical seizure status in rats. Epilepsia 48, 348–358.
Tomita, S., Chen, L., Kawasaki, Y., Petralia, R.S., Wenthold, R.J., Nicoll, R.A.,
and Bredt, D.S. (2003). Functional studies and distribution define a family of
transmembrane AMPA receptor regulatory proteins. J. Cell Biol. 161, 805–816.
Traynelis, S.F., Wollmuth, L.P., McBain, C.J., Menniti, F.S., Vance, K.M., Og-
den, K.K., Hansen, K.B., Yuan, H., Myers, S.J., and Dingledine, R. (2010).
Glutamate receptor ion channels: structure, regulation, and function. Pharma-
col. Rev. 62, 405–496.
Twomey, E.C., Yelshanskaya, M.V., Grassucci, R.A., Frank, J., and Sobolev-
sky, A.I. (2016). Elucidation of AMPA receptor-stargazin complexes by cryo-
electron microscopy. Science 353, 83–86.
Twomey, E.C., Yelshanskaya, M.V., Grassucci, R.A., Frank, J., and Sobolev-
sky, A.I. (2017a). Channel opening and gating mechanism in AMPA-subtype
glutamate receptors. Nature 549, 60–65.
Twomey, E.C., Yelshanskaya, M.V., Grassucci, R.A., Frank, J., and Sobolev-
sky, A.I. (2017b). Structural Bases of Desensitization in AMPA Receptor-Auxil-
iary Subunit Complexes. Neuron 94, 569–580.
von Engelhardt, J., Mack, V., Sprengel, R., Kavenstock, N., Li, K.W., Stern-
Bach, Y., Smit, A.B., Seeburg, P.H., and Monyer, H. (2010). CKAMP44: a
brain-specific protein attenuating short-term synaptic plasticity in the dentate
gyrus. Science 327, 1518–1522.
Willems, J., de Jong, A.P.H., Scheefhals, N., Mertens, E., Catsburg, L.A.E.,
Poorthuis, R.B., de Winter, F., Verhaagen, J., Meye, F.J., and MacGillavry,
H.D. (2020). ORANGE: A CRISPR/Cas9-based genome editing toolbox for
epitope tagging of endogenous proteins in neurons. PLoS Biol. 18, e3000665.
Wolff, M., Gibb, S.J., and Dalrymple-Alford, J.C. (2006). Beyond spatial mem-
ory: the anterior thalamus and memory for the temporal order of a sequence of
odor cues. J. Neurosci. 26, 2907–2913.
Wright, N.F., Erichsen, J.T., Vann, S.D., O’Mara, S.M., and Aggleton, J.P.
(2010). Parallel but separate inputs from limbic cortices to the mammillary
bodies and anterior thalamic nuclei in the rat. J. Comp. Neurol. 518, 2334–
2354.
Wu, G., Lu, Z.H., Wang, J., Wang, Y., Xie, X., Meyenhofer, M.F., and Ledeen,
R.W. (2005). Enhanced susceptibility to kainate-induced seizures, neuronal
apoptosis, and death in mice lacking gangliotetraose gangliosides: protection
with LIGA 20, a membrane-permeant analog of GM1. J. Neurosci. 25, 11014–
11022.
Zhao, Y., Chen, S., Swensen, A.C., Qian, W.J., and Gouaux, E. (2019). Archi-
tecture and subunit arrangement of native AMPA receptors elucidated by
cryo-EM. Science 364, 355–362.
Zheng, Y., Mellem, J.E., Brockie, P.J., Madsen, D.M., and Maricq, A.V. (2004).
SOL-1 is a CUB-domain protein required for GLR-1 glutamate receptor func-
tion in C. elegans. Nature 427, 451–457.






REAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
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NBQX Tocris 1044
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Mouse: GSG1L / / CACNG2 / This paper N/A
Rat: GSG1L / (Izsvák et al., 2010) PMID: 21193047
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Genotyping Primer GSG1L, mouse, left: aaacagacaacatggccctcagactc Sigma N/A
Genotyping Primer GSG1L, mouse right: gacttgtcccatctctaggatacctccc Sigma N/A
Genotyping Primer GSG1L, rat, left: acgttgtagtgaccccaagc Sigma N/A
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Genotyping Primer CACNG2, mouse, left: atggtgttgagaattcggctgtacc Sigma N/A
Genotyping Primer CACNG2, mouse, right: aaccctaaggactccaaagcatcc Sigma N/A
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Prism 6.0 Graphpad Software https://www.graphpad.com/scientific-
software/prism/








LabView National Instruments https://www.ni.com/en-us/shop/
labview/labview-details.html
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Further information and requests for resources and reagents should be directed to the Lead Contact, Terunaga Nakagawa (terunaga.
nakagawa@vanderbilt.edu).
Materials availability
Requests that are related to mouse lines, should be directed to the lead contact.
Data and code availability
The data generated during this study are available from the lead contact upon reasonable request.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
All animal procedures were approved by the Vanderbilt University Animal Care and Use Committee and were in agreement with the
NIH and Vanderbilt University guidelines for the care and use of laboratory animals.Maturemice and rats were housedwith same-sex
littermates and maintained on a 12hr light/dark cycle under controlled temperature and humidity. Food and water were provided ad
libitum.
AGSG1L knockout (KO) transgenicmouse line was generated by targeting exon 4 of GSG1L gene in 129/SvEvTac embryonic stem
(ES) cells. Two independent clones were shown by Southern blot analysis and PCR to have undergone proper homologous recom-
bination and germline transmission was confirmed from chimeras derived from clone 2H2. To remove the pGK-neo cassette, the
3-loxP mouse was crossed with FlpE line (Rodrı́guez et al., 2000) that ubiquitously expresses Flp recombinase, generating a
2-loxP animal. Finally, by crossing with EIIa-cre mice (JAX: Stock 003724, which was backcrossed with C57BL6/J over 10 genera-
tions) that expresses cre-recombinase in the one cell zygote, we obtained the 1-loxP heterozygotes. All strains were backcrossed
with C57BL6/J mice for 8 generations. All KO animals were viable with no overt issues with breeding and/or development.
The g-2 KO mouse was generated as follows: A 20 bp sequence (TGAAACCAGCAAGAAGAACG, boxed in Figure S4) followed by
AGGas proto-spacer adjacentmotif (PAM), was selectedwithin exon 1 of theCACNG2 (encoding g-2)mouse gene to create a target-
specific guide RNA molecule. The sequence flanked by BbsI sites was ligated in pX330, a vector expressing the guide RNA under a
strong U6 promoter and cas9 under a hybrid chicken beta-actin (Cbh) promoter. The vector was injected alongside a 195 base repair
single stranded oligonucleotide into 314 mouse embryos. The repair oligo contained 90 bp homology arms, a codon substituting
lysine residue 53 to a stop codon, a unique AgeI restriction site, and a few additional third base mutations to prevent targeting of
cas9 to the repaired DNA (Figure S4). Out of 314 embryos injected, 267 were transferred to 11 pseudo-pregnant females to generate
16 pups. At weaning, genotypingwas done by amplifying a 926 bp fragment followed by sequencing. Out of 15 pups (one died prior to
weaning), only one animal (female #12) carried the designed mutation. After several backcrossing to C57BL6/J mice to eliminate any
possible off target events, heterozygote mice were crossed to generate homozygous KO animals.
A transgenic GSG1L KO rat line in the background of SD strain was among the mutants generated through transposon-based
mutagenesis by Kent Hamra at UT Southwestern (Izsvák et al., 2010). The mutant rat line was purchased and maintained in house.
For each experiment, both male and female animals were used. Each cohort contained roughly equal number of each sex. For
short-term plasticity experiments comparing the three pathways, GSG1L KO andWTmice P21-P33 were used. For short-term plas-
ticity experiments of AD only, AD/AV combined, NMDAR-dependent, and CTZ recordings were done at P15-P30. For mEPSCs,
sEPSCs, qEPSCs and current clamp recordings of GSG1L KO and WT mice at P15-P30 were used. For mEPSCs and sEPSCs of
g-2 KO and WT (and GSG1L/ g-2 dKO) mice at P15-P22 were used. For behavioral experiments, GSG1L KO and WT mice at
9-10 month old were used. LacZ staining of GSG1L KO rat and WT control littermates was done as indicated in the figures: P14,
P21, P60, and P180.
Genotyping by PCR
PCR amplification was conducted with the following primers:
GSG1L KO mice: GSG1L left: aaacagacaacatggccctcagactc; GSG1L right: gacttgtcccatctctaggatacctccc.
GSG1L KO rats: Gsg1L left: acgttgtagtgaccccaagc; GSG1L right: tgcacgcatactacaatga; SFB2: tcatcaaggaaaccctggac
g-2 KO mice: CAC9: atggtgttgagaattcggctgtacc; CAC10: aaccctaaggactccaaagcatcc
METHOD DETAILS
Electrophysiology in acute slices
For all electrophysiology experiments that were done in the AT, mice of both sexes aged were used. Using the stria medullaris (sm)
and the hippocampus as anatomical landmarks, we unambiguously identified AD/AV in 300 mm-thick coronal sections. For short-
term plasticity experiments, the C-T synapse was isolated in a coronal slice configuration and the cortical inputs were stimulated




outside of AD/AV (as illustrated in Figures 1H and 1I). M-T synapses were isolated in 300 mm-thick sagittal brain sections. The prom-
inent MTT and the hippocampus were used as anatomical landmarks to identify the AD/AV. To stimulate this synapse, the stimulating
electrode was placed directly on the MTT. The S-T synapse was isolated in 300 mm-thick sagittal brain sections. The MTT and the
hippocampus were used as landmarks to isolate the AD/AV and the electric stimulator was placed on the subiculum inputs directly
below the hippocampus.
Mice were decapitated and the brains were rapidly removed and placed in ice-cold N-methyl-D-glucamine (NMDG) cutting solu-
tion containing 92 mM NMDG, 2.5 mM KCl, 30 mM NaHCO3, 1.25 mM NaH2PO4, 11 mM Glucose, 0.5 mM CaCl2, 10 mM MgCl2,
20 mMHEPES, 2 mM thiourea, 5 mMNa-ascorbate, 3 mMNa-pyruvate, with pH adjusted to 7.4 with HCl. Acute 300 mm-thick slices
were prepared using a vibratome (Leica VT 1200). Slices were then left to recover for 1 hr in artificial cerebro-spinal fluid (aCSF) so-
lution containing 119 mMNaCl, 2.5 mMKCl, 26 mMNaHCO3, 1 mMNaH2PO4, 11 mMGlucose, 1 mMMgCl2, 2 mMCaCl2, at pH 7.4
and 310 mOsm, saturated with 95%O2/ 5% CO2.
For AMPAR-mediated mEPSCs recordings, the aCSF was supplemented with tetrotodoxin (TTX, 0.5 mM) in order to suppress
spontaneous excitation. To specifically isolate AMPAR-mediated mEPSCs at a holding potential of70mV, GABA-A receptor activ-
ity was blockedwith 100 mMpicrotoxin (Tocris). For AMPAR-mediated sEPSCs recordings, the aCSFwas supplementedwith 100 mM
picrotoxin to isolate the AMPAR component at 70 mV. Pipettes were filled with the internal solution containing 115 mM Cs meth-
anesulfonate, 20mMCsCl, 10mMHEPES, 2.5mMMgCl2, 4mMNa2ATP, 0.4mMNa3GTP, 10mMNa phosphocreatine, and 0.6mM
EGTA. The osmolarity was adjusted to 295 mOsm and the pH was adjusted to 7.25 with CsOH. The patches were formed with bo-
rosilicate glass pipettes (O.D. 1.5mm, I.D. 0.86mm, Sutter) (3-5 MU tip resistance). Recordings were made using Multiclamp 700B
Amplifier (Axon Instruments) operated by pCLAMP10 software, low-pass filtered at 10 kHz and digitized at 20 kHz using Digida-
ta1440A (Axon Instruments). Obtained mEPSCs and sEPSCs events were detected and analyzed with NeuroMatic event detection
software (IGOR-pro, Wavemetrics) and correct event detection was confirmed by manual visual inspection, while errors were cor-
rected by manual inspection of the traces. All the recordings and analysis were done in a blind manner, with the experimenter blind
to the genotype during data acquisition and analysis. Significance was determined with Mann-Whitney U-test or a two-way analysis
of variance (Two-Way ANOVA) with Sidak’s multiple comparison post hoc test when applicable.
To evoke asynchronous quantal EPSCs (qEPSCs), Ca2+ was replaced with Sr2+ (4 mM SrCl2). In order to avoid the multiquantal
events, we only analyzed the qEPSCs that occurred > 10 ms following the stimulation with the total sweep duration of 360 ms. Ob-
tained qEPSC events were detected and analyzed with NeuroMatic event detection software (an extension to the IGOR-pro, Wave-
metrics) and correct event detection was confirmed, while errors were corrected bymanual inspection of the traces. The kinetic anal-
ysis of qEPSCs andmEPSCswere also done using NeuroMatic and IGOR-pro. From each corresponding cell, all isolated events with
flat baselinewere used for analysis. Typically, from each cell 15-30 representative events withmonotonic rise and distinct decaywere
selected and averaged. The decay time of averaged qEPSCs was determined by fitting to double exponential function. The weighted
decay time constant was further calculated as sum of slow and fast time constants and weighted by fractional amplitudes (Hawken
et al., 2017).
For short-term plasticity experiments, whole-cell recordings AD/AV neurons were achieved in response to electrical stimulation of
MTT, subiculum, or the cortical inputs at a holding potential of 70 mV. For M-T recordings, 300 mm-thick acute sagittal slices with
AD/AV and visible MTT were obtained. The MTT was electrically stimulated, and current changes were recorded in response to
5-pulse stimulation at 20 Hz and 50 Hz. For S-T recordings, 300 mm-thick acute sagittal slices with AD/AV were obtained. Similarly,
the subiculum inputs (as depicted in Figure 2) were stimulated at 20 Hz and 50 Hz. For C-T recordings, 300 mmthick acute coronal
slices with AD/AV were obtained and the cortical inputs (as depicted in Figure 2) were electrically stimulated at 20 Hz and 50 Hz.
Slices were perfused with aCSF supplemented with 100 mM picrotoxin. To isolate the effect of CTZ on short-term plasticity, we
bath applied aCSF supplemented with 100 mM CTZ (Tocris). NMDAR currents were recorded as aforementioned, but at a holding
potential of +40 mV and in the presence of 10 mM NBQX and 100 mM picrotoxin. Statistical significance was assessed using a
two-way analysis of variance (Two-Way ANOVA) with Sidak’s multiple comparison post hoc test.
Intrinsic excitability properties were analyzed in current clamp recording mode. The recordings were done using potassium-based
internal solution containing: 115mM K methanesulfonate, 20 mM KCl, 10 mM HEPES, 2.5 mM MgCl2, 4 mM Na2ATP, 0.4 mM
Na3GTP, 10 mM Na phosphocreatine, 0.6 mM EGTA. The osmolarity was adjusted to 295 mOsm and the pH was adjusted to pH
7.25 with KOH. In order to measure the intrinsic excitability properties, the neurons were held at 70 mV and current was injected
in 10 pA increments (from20 to 160 pA) for 200ms. The rheobase was determined as aminimal current injection required to elicit an
action potential firing. The firing rate was determined as the number of action potentials fired at 150 pA injection. The input resistance
was determined by calculating the slope of current-voltage plot (20 to 20 pA). The firing frequency of spiking GSG1L KO neurons
was determined, by calculating the frequency of fired action potentials during a 50 msec recording period.
Fast glutamate application from outside out patches
TetON HEK cells were plated on a coverglass coated with poly-D-lysine (37.5 mg/ml in H2O) for 15 min. Excess coating material was
removed by washing in D-PBS three times. Cells were plated and incubated on a coverglass until they were adherent (typically within
12 hr) and transfected with a plasmid (DualpTREt-GluA2i(Q)+GSG1L) that DOX dependently express GluA2flip(Q) and GSG1L. After
transfection, 30 mMNBQX and 5 mg/ml doxycycline (DOX) were added. Cells were used for recording 24-36 hr after induction. Ligand
(1mM glutamate) was applied via theta tubing glass capillary mounted on a piezo actuator (P-830.30, Physik Instrumente) controlled




by an LVPZT amplifier (E-505, Physik Instrumente), DAQ device (NI USB-6221, National Instruments), and LabView software (Na-
tional Instruments). Recording was done using a single channel of a Multiclamp700B Amplifier (Axon Instruments) operated by
pCLAMP10 software. Signals were digitized using Digidata1440A (Axon Instruments) at a sampling rate of 50 kHz and low pass
filtered at 2kHz. Borosilicate glass capillaries (O.D. 1.5 mm, I.D. 0.86 mm, Sutter) were pulled to manufacture electrodes with pipette
resistances of 4-5MU. Internal solution was (in mM) 110NaCl, 10NaF, 5 EGTA, 0.5 CaCl2, 1MgCl2, 10 Na2ATP, 5 HEPES, adjusted to
pH 7.3 with CsOH and 295 mOsm. External solution was (in mM) 145 NaCl, 2.5 KCl, 1.8 CaCl2, 1 MgCl2, 5 HEPES, 10 glucose,
adjusted to pH 7.3 with NaOH and 301 mOsm. Standard solution without ligand was the external solution. The ligand solution con-
tained 1mMglutamate in external solution, supplemented with 2mMglucose and 3mMNaCl to facilitate the visualization of the inter-
face of the two solutions and recording liquid junction potential after breaking the patch. A protocol for four 1ms glutamate pulses at




To investigate seizure susceptibility behavior, GSG1L KO and WT littermates of both sexes (9-10 month old) were administered an
intraperitoneal (i.p.) injection of kainic acid monohydrate (Sigma) dissolved in 0.9% saline solution at 15 mg/kg or 25 mg/kg body
weight. Seizure susceptibility was determined immediately following the kainate injections. Seizure activity was video recorded
for 2 hr and scored for severity using a previously described seizure severity scale in a blind manner, with the experimenter blind
to the genotype during scoring (Morrison et al., 1996; Wu et al., 2005; Bateup et al., 2013). Seizure severity was assessed at a
five-minute interval.
The severity of seizures was assigned based on the following chart:
0, no abnormality;
1- immobility, cessation of normal behavior;
2- rigid posture with extended tail or forelimbs;
3- repetitive behaviors including head nodding, head bobbing, twitching, or scratching;
4- Forelimb clonus with partial or intermittent rearing;
5- continuous forelimb clonus/rearing or repeated rearing and falling;
6- loss of posture, generalized tonic-clonic whole body convulsions or hyperactivity/jumping behavior;
7- mortality.
Novel object recognition task
GSG1L KO andWT littermates of both sexes (9-10 month old) were habituated for 10 min in an empty novel object recognition arena
(403 643 33 cm3) on day 1. The following day, the mice were placed in the novel object recognition arena that contained two iden-
tical objects and were allowed to explore the space for 10 min. Following the habituation phase, mice were placed back into their
homecage for 1 hr. During probe phase, one of the familiar (previously exposed) objects was replaced with a novel object. The explo-
ration behavior was recorded for 10min. Time spent exploring familiar and novel objects was scored blindly and the recognition index
was identified as (time exploring novel object)- (time exploring familiar object) / total time exploring both objects.
Rotarod
Motor coordination and balance were measured by placing the mice on an accelerating rotating rod (Ugo Basile model 7650; Stoelt-
ing Co., Wood Dale, IL, USA). The initial rotations per minute (rpm) were set at 4 rpm, which gradually increased to 40 rpm. The per-
formance of each animal was recorded over the course of 300 s. The time taken for a mouse to fall off the rod was recorded by an
observer blinded to themouse genotype. The test was conducted over the course of three dayswith three independent trials per day.
Elevated Zero Maze
Anxiety was measured using elevated zero maze (San Diego Instruments, CA). The device is an elevated ring-shaped platform with
four equal chambers (two open arms and two closed arms). Light levels in the closed arms were at approximately 100 lux and 200 lux
in open arms. Mice were placed in the center of an open arm and allowed to explore the maze for 5 min. The activity was video-re-
corded and analyzed using ANY-maze software (Stoelting, Wood Dale, Illinois, USA).
Grip strength
Grip strength wasmeasured using aGrip Strength Test Apparatus (San Diego Instruments, CA). The grip strength wasmeasured by a
digital gauge over 7 independent trials. The average grip strength was calculated as an average of 7 trials (in Newtons).





GSG1L KO (P14, P21, P60, P180) rat brains with corresponding WT rat animals were anesthetized with sodium pentobarbital
(Nembutal). Each animal was then perfused with normal rat Ringer solution (pH 7.4) for 2 min to ensure complete perfusion, followed
by 4%paraformaldehyde in 0.1Mphosphate (pH 7.4) buffer for 4min. Obtained brains were further fixed for 15min. Fixed brains were
subsequently sectioned to generate 300 mm-thick coronal sections using a vibratome (Leica VT 1200). The sections were then per-
meabilizedwith 0.01%Sodiumdeoxycholate and 0.02%Triton X-100 in PBS buffer for 2 hr. Following permeabilization, 300 mm-thick
coronal sections were incubated with X-gal staining solution containing: 5 mM K3[Fe(CN)6], 5 mM K4[Fe(CN)6], 2 mM MgCl2, 0.02%
Triton X-100, and 0.1% X-gal in PBS buffer at 37C for 8 hr in the dark. Stained brains were imaged (MULTIZOOM AZ100M, Nikon
microscope) following day (1 day post staining).
Confirming the absence of targeted proteins in the KO animals
Immunoprecipitation of protein complexes were performed as previously described (Nakagawa et al., 2005). Briefly, mouse (or rat)
brains were homogenized in 20 mM HEPES pH 7.4, 320 mM sucrose, 5 mM EDTA, 5 mM EGTA, 30 mM NBQX supplemented with
protease inhibitors 1 mM PMSF, 10 mg/ml aprotinin, 10 mg/ml leupeptin, 1 mg/ml pepstatin, and 500 mM benzamidine. Brain homog-
enates were spun down at 3000 g for 15min and the obtained supernatant was further spun at 38,400 g for 15min resulting in amem-
brane pellet. The membrane pellet was resuspended in a buffer containing 20 mM HEPES pH 7.4, 1 M KI, 5 mM EDTA, 5 mM EGTA,
and 30 mM NBQX. To wash off the KI, membranes were washed with wash buffer containing 20 mM HEPES pH 7.4, 5 mM EDTA,
5 mM EGTA, and 30 mM NBQX. The final membrane pellet was solubilized in a resuspension buffer containing 20 mM HEPES pH
7.4, 100 mM NaCl, 5 mM EDTA, 5 mM EGTA, 1% CHAPS, 30 mMNBQX and the protease inhibitors for two hours at 4C. To validate
GSG1L 3-loxP KO, GSG1L was immunoprecipitated with previously described anti-GSG1L Ct2 antibody (2mg/ml) and eluted with
the epitope peptide CKVFEQGYREEPTFIDPEAIKYFR (Shanks et al., 2012). To validate GSG1L 1-loxP KO, GSG1L was immunopre-
cipitated with anti-GSG1L Ct1 antibody (2mg/ml) and eluted with the epitope peptide CRSSAHEAAELNRQCWVLGHWV (Shanks
et al., 2012). Immunoprecipitated GSG1L from the brain lysates of 3-loxP KO and 1-loxP KOGSG1Lwas then probed in western blots
with anti-GSG1L Ct1 antibody and Ct2 antibody, respectively. Of note, long and short isoforms of GSG1L transcripts are listed in the
mouse genome database. The short isoform is predicted to lack the Ct2 epitope, and thus we were only able to confirm the KO of
43kDa long isoform of GSG1L. The short isoform lacks the TM4, which is essential for binding AMPAR from the cryo-EM structure
(Twomey et al., 2017b), and unlikely to have a role in regulating AMPAR. The folding of TM1-TM4 is highly conserved among the tet-
raspanins and therefore loss of TM4 is likely to cause a substantial misfolding in the short isoform. Specifically, if the short isoform
exists, it would have an extracellular C-terminal, whose topology is completely different from the long isoform with a cytoplasmic
C-terminal. Moreover, our targeting design does not permit efficient transcription of the shorter isoform given that exon 4, upstream
of the putative splice site, is targeted. Collectively, we suggest that the short isoform is unlikely to exist and only the long isoform is
relevant in the current study. We also note that the observed differences in the non-specific band patterns in Figure S1I is a
consequence of using different polyclonal antibodies for detection. Note that the band immediately below GSG1L in 1loxp KO
blot is due to nonspecific binding (Figure S1I). For validating g-2 KO, AMPAR complexes were pulled down with anti-GluA2 antibody
(EGYNVYGIESVKI). Immunoprecipitated stargazin was probed with anti-stargazin antibody (Millipore, AB9876).
QUANTIFICATION AND STATISTICAL ANALYSIS
All statistical analyses were performed with Graphpad Prism. Data in the figures are represented as mean ± SEM. The information on
statistical tests used, sample sizes (n) and animal subjects (N) are present in figure legends. Statistical significance for averaged data
from multiple experiments was determined using Mann-Whitney U test or Two-Way Analysis of Variance (ANOVA) followed by Post
hoc analysis. Error bars in all figures represent standard error of the mean. The cumulative probability difference was determined
using Kolmogorov-Smirnov test.
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